3 completed, 1 recruiting. 2 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow Relapsed Lymphoma: new trials by email Literature Review of Relapsed Lymphoma trials Research Report on Relapsed Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Epco, Zanu, Ritux for R/R FL or MZL Zanubrutinib, Rituximab, Epcoritamab - Follicular Lymphoma, Lymphoma | Phase 2 | Recruiting | Reid Merryman, MD | 71 | 2025-01-21 | 2026-09-25 |
| Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma fimepinostat, Rituximab, venetoclax - Lymphoma, Relapsed Lymphoma | Phase 1 | Completed | Curis, Inc. | 106 | 2012-12-01 | 2021-05-06 |
| Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors Cognitive-behavioral therapy for worry, uncertainty & insomnia - Anxiety Disorder, Worry | Not applicable | Completed | Ohio State University Comprehensive Cancer Center | 33 | 2011-08-01 | 2017-04-05 |
| Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma gallium nitrate - Non-Hodgkin's Lymphoma, Relapsed Lymphoma | Phase 2 | Completed | Genta Incorporated | 40 | 2002-06-01 | 2006-02-08 |
Lymphoma (4) · Lymphoma, Non-Hodgkin (2) · Anxiety Disorders (1) · Depression (1) · Esophageal Neoplasms (1) · Fatigue (1) · Glioblastoma (1) · Leukemia (1) · Lung Neoplasms (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1) · Multiple Myeloma (1) · Neoplasms (1) · Ovarian Neoplasms (1)
Hemic and Lymphatic Diseases (4) · Immune System Diseases (4) · Immunoproliferative Disorders (4) · Lymphatic Diseases (4) · Lymphoproliferative Disorders (4) · Neoplasms by Histologic Type (4) · Neoplasms (3) · Lymphoma, B-Cell (2) · Pathological Conditions, Signs and Symptoms (2) · Adnexal Diseases (1) · Astrocytoma (1) · Behavior (1) · Behavioral Symptoms (1) · Blood Protein Disorders (1) · Cardiovascular Diseases (1)
Rituximab (2) · Acceptance and Commitment Therapy (1) · Behavior Therapy (1) · CUDC-907 (1) · Cognitive Behavioral Therapy (1) · Psychosocial Intervention (1) · Uncertainty (1) · fimepinostat (1) · gallium nitrate (1) · venetoclax (1) · zanubrutinib (1)
Curis, Inc. (1) · Genta Incorporated (1) · Ohio State University Comprehensive Cancer Center (1) · Reid Merryman, MD (1)
United States (4)
Reid Merryman, MD (1) · Sharla Wells-Di Gregorio, Ph.D. (1)